P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa

Documenti analoghi

• Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women.
  di: Mary H Latka, et al.
  Pubblicazione: (2012-01-01)
• HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials
  di: Volk JE, et al.
  Pubblicazione: (2012-09-01)
• P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
  di: Magagula D, et al.
  Pubblicazione: (2009-10-01)
• P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
  di: Roux S, et al.
  Pubblicazione: (2009-10-01)
• Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.
  di: Kathryn L Hopkins, et al.
  Pubblicazione: (2014-01-01)